Share on LinkedInShare on LinkedIn

ARTICLE · 24 FEBRUARY 2024

Showing Examiner Error In Advanced Bionics Framework Based On Arguments And Evidence Patent Owner Presented During Prosecution

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

In Samsung Bioepis Co, Ltd. v. Alexion Pharms., Inc., IPR2023-01070, Paper 9 (PTAB Dec. 19, 2023), the Patent Trial and Appeal Board ("the Board")...

United StatesIntellectual Property

Holding

In Samsung Bioepis Co, Ltd. v. Alexion Pharms., Inc., IPR2023-01070, Paper 9 (PTAB Dec. 19, 2023), the Patent Trial and Appeal Board ("the Board") instituted an inter partes review ("IPR") petition challenging all claims of U.S. Pat. No. 10,703,809 ("the '809 patent") related to Alexion's product eculizumab, marketed as Soliris®. In doing so, the Board rejected Patent Owner's 35 U.S.C. §325(d) discretionary denial arguments.

Background

Petitioner asserted twelve grounds of obviousness based on various combinations of nine references.

Board Decision

The Board found Petitioner carried its burden to show a reasonable likelihood of showing obviousness of at least one challenged claim. In granting institution, the Board analyzed Patent Owner's §325(d) arguments and determined not to exercise its discretion to deny institution based on its analysis under the two-part Advanced Bionics framework:1

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from